Clinical Trial Update: Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for varenicline in Parkinson's disease, terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED